Free Trial
TSE:CXF

CI Canadian Convertible Bond ETF Common (CXF) Stock Price, News & Analysis

CI Canadian Convertible Bond ETF Common logo
C$10.03
0.00 (0.00%)
(As of 11/1/2024 ET)

About CI Canadian Convertible Bond ETF Common Stock (TSE:CXF)

Key Stats

Today's Range
C$10.03
C$10.03
50-Day Range
C$9.73
C$10.21
52-Week Range
C$8.32
C$10.36
Volume
N/A
Average Volume
5,959 shs
Market Capitalization
C$61.15 million
P/E Ratio
N/A
Dividend Yield
4.79%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs include ONC201 a program for treating tumors which harbor the H3 K27M mutation in recurrent diffuse midline glioma patients; ONC206, an imipridone, Dopamine Receptor D2 (DRD2) antagonist, and caseinolytic protease P (ClpP) agonist that demonstrated enhanced non-competitive DRD2 antagonism relative to ONC201, which is in Phase I clinical trials to treat solid tumors; ONC212, an imipridone agonist of the orphan G protein-coupled receptors (GPCR) tumor suppressor GPR132, as well as ClpP for solid tumors and hematological malignancies, including pancreatic cancer and leukemias; and dociparstat sodium (DSTAT), which inhibits the activities of key proteins implicated in the resistance of acute myeloid leukemia blasts and leukemic stem cells to chemotherapy. The company has license agreements with Biomedical Advanced Research and Development Authority for the development of brincidofovir for use in the treatment of smallpox; Cantex Pharmaceuticals, Inc. to develop and commercialize a glycosaminoglycan compound; and SymBio Pharmaceuticals to develop, manufacture, and commercialize BCV for various human indications. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina.

Receive CXF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CI Canadian Convertible Bond ETF Common and its competitors with MarketBeat's FREE daily newsletter.

CXF Stock News Headlines

ETHXF CI GALAXY ETHEREUM ETF
Miller Convertible Bond I
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
CMNY:CA CI Money Market ETF
ICVT ETF Stock Price History
See More Headlines

CXF Stock Analysis - Frequently Asked Questions

CI Canadian Convertible Bond ETF Common's stock was trading at C$9.04 at the beginning of the year. Since then, CXF stock has increased by 11.0% and is now trading at C$10.03.
View the best growth stocks for 2024 here
.

Shares of CXF stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that CI Canadian Convertible Bond ETF Common investors own include Golden Minerals (AUMN), Tesla (TSLA), iA Financial (IAG), Northland Power (NPI), Allied Properties Real Estate Investment Trust (AP.UN), Capital Power (CPX) and Enerplus (ERF).

Company Calendar

Ex-Dividend for 9/27 Dividend
9/23/2024
Dividend Payable
9/27/2024
Ex-Dividend for 10/31 Dividend
10/25/2024
Dividend Payable
10/31/2024
Today
11/02/2024

Industry, Sector and Symbol

Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceutical Products
CIK
N/A
Web
N/A
Fax
N/A
Employees
90
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
C$61.15 million
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own in 2025 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report

This page (TSE:CXF) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners